This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ROBERT C. SURRIDGE, M.D.; WILLIAM P. KROGER, M.D.

AMA Arch Surg. 1961;82(6):910-915.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Cancer of the thyroid gland has led to a great deal of controversy in the literature. There has been much disagreement as to incidence, classification, geographic relationship, diagnosis, and treatment of malignant disease of the thyroid gland.

The reported incidence of carcinoma of the thyroid varies from 1% to as high as 24%. This wide variation is largely due to 3 main factors—(1) the geographic location in which the survey of goiter is made; (2) the difference in the pathologic grading of carcinoma by microscopic change in the thyroid tissue, and (3) the manner in which various authors segregate the types of goiter from which cancer may arise. For example, the incidence of cancer developing in toxic diffuse goiter is very low (about 0.2%), the incidence in toxic nodular goiter is about 1%, while the reported incidence of cancer in nontoxic nodular goiter ranges from 6% to as high as . . . [Full Text PDF of this Article]

Author Affiliations
LOS ANGELES

Footnotes
This paper was read at the 68th Annual Meeting of the Western Surgical Association, Detroit, Dec. 2, 1960.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?